277 related articles for article (PubMed ID: 7597787)
21. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
Brown WC; Palmer GH
Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
[TBL] [Abstract][Full Text] [Related]
23. Culture-derived parasites in vaccination of cattle against tick-borne diseases.
Shkap V; Pipano E
Ann N Y Acad Sci; 2000; 916():154-71. PubMed ID: 11193616
[TBL] [Abstract][Full Text] [Related]
24. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
[TBL] [Abstract][Full Text] [Related]
25. Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance.
Pipano E
Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):86S-90S. PubMed ID: 9512751
[TBL] [Abstract][Full Text] [Related]
26. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle--a review.
Dalgliesh RJ; Jorgensen WK; de Vos AJ
Trop Anim Health Prod; 1990 Feb; 22(1):44-52. PubMed ID: 2181745
[No Abstract] [Full Text] [Related]
27. Immune control of Babesia bovis infection.
Brown WC; Norimine J; Knowles DP; Goff WL
Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
[TBL] [Abstract][Full Text] [Related]
28. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
Montenegro-James S
Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
[TBL] [Abstract][Full Text] [Related]
29. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species.
Tjornehoj K; Lawrence JA; Whiteland AP; Kafuwa PT
Onderstepoort J Vet Res; 1996 Mar; 63(1):1-5. PubMed ID: 8848296
[TBL] [Abstract][Full Text] [Related]
30. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
Montenegro-James S; Toro M; Leon E; Guillen AT
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
[TBL] [Abstract][Full Text] [Related]
31. Co-immunization of cattle with a vaccine against babesiosis and Lactobacillus casei increases specific IgG1 levels to Babesia bovis and B. bigemina.
Bautista-Garfias CR; Lozano AR; Martínez CR; Martínez JA; Millán JV; García GR; Castañeda-Arriola R; Aguilar-Figueroa BR
Parasitol Int; 2015 Oct; 64(5):319-23. PubMed ID: 25936971
[TBL] [Abstract][Full Text] [Related]
32. Development of conventional subunit vaccines for anaplasmosis and babesiosis.
Montenegro-James S; Johnson WC; Goff WL
Vet Parasitol; 1995 Mar; 57(1-3):255-66. PubMed ID: 7597788
[TBL] [Abstract][Full Text] [Related]
33. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium.
Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ
Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165
[TBL] [Abstract][Full Text] [Related]
34. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
Brown WC
Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
[TBL] [Abstract][Full Text] [Related]
35. Bovine anaplasmosis and babesiosis in the Lesser Antilles: risk assessment of an unstable epidemiologic situation.
Camus E; Montenegro-James S
Vet Res; 1994; 25(2-3):313-7. PubMed ID: 8038806
[TBL] [Abstract][Full Text] [Related]
36. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle.
Brown WC; Palmer GH; McElwain TF; Hines SA; Dobbelaere DA
Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411
[TBL] [Abstract][Full Text] [Related]
37. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
38. A conserved motif in the immune-subdominant RAP-1 related antigen of
Rojas MJ; Bastos RG; Navas J; Laughery JM; Lacy PA; Suarez CE
Front Immunol; 2024; 15():1380660. PubMed ID: 38720894
[TBL] [Abstract][Full Text] [Related]
39. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina.
Späth EJ; Mangold AJ; Guglielmone AA
Vet Parasitol; 1990 May; 36(1-2):131-40. PubMed ID: 2382381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
